AlphaFold predicted structure
NEK1 · Q96PY6


Mean pLDDT
56.8/ 100
Low
1,258 residues
Confidence breakdown
- Very high(≥ 90)17%
- Confident(70–90)27%
- Low(50–70)7%
- Very low(< 50)49%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
NIMA related kinase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Adult onset neurodegenerative disorder
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownAmyotrophic lateral sclerosis/motor neuron disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownClefting
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalRare multisystem ciliopathy disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal ciliopathies
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomal+8 more panels — install the extension to see the full list inline on any page.
short-rib thoracic dysplasia 6 with or without polydactyly
short rib-polydactyly syndrome
amyotrophic lateral sclerosis
Orofaciodigital syndrome type 2
orofaciodigital syndrome type II
smoking initiation
connective tissue disorder
motor neuron disorder
short rib-polydactyly syndrome, Majewski type
asphyxiating thoracic dystrophy 3
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Serine/threonine-protein kinase Nek1
Phosphorylates serines and threonines, but also appears to possess tyrosine kinase activity (PubMed:20230784). Involved in DNA damage checkpoint control and for proper DNA damage repair (PubMed:20230784). In response to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to limit mitochondrial cell death (PubMed:20230784). May be implicated in the control of meiosis (By similarity). Involved in cilium assembly (PubMed:21211617)
Curated MONDO disease pages that list NEK1 among their top associated genes.
NEK1 · Q96PY6


Mean pLDDT
56.8/ 100
Low
1,258 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0